CAS: 2290608-13-6
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | VT103 REF: 54-BUP08601CAS: 2290608-13-6 | ≥98% | 1.148,00 €~4.633,00 € | Ven 09 Mag 25 |
 | N-Methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide REF: 3D-QRD60813CAS: 2290608-13-6 | Min. 95% | Prezzo su richiesta | Ven 20 Giu 25 |
 | VT103 REF: TM-T62077CAS: 2290608-13-6 | 98.73% | 124,00 €~3.690,00 € | Gio 26 Giu 25 |
Ref: 54-BUP08601
| 25mg | 1.148,00 € | ||
| 50mg | 1.866,00 € | ||
| 100mg | 2.533,00 € | ||
| 500mg | 4.633,00 € |
Consegna stimata in Stati Uniti, il Venerdì 09 Maggio 2025
N-Methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide
CAS:2290608-13-6
Please enquire for more information about N-Methyl-3-(1-methyl-1H-imidazol-4-yl)-4-((4-(trifluoromethyl)phenyl)amino)benzenesulfonamide including the price, delivery time and more detailed …
Formula:
C18H17F3N4O2S
Purezza:
Min. 95%
Peso molecolare:
410.4 g/mol
Ref: 3D-QRD60813
| 10mg | 1.014,00 € | ||
| 25mg | 1.559,00 € | ||
| 50mg | 2.429,00 € |
Consegna stimata in Stati Uniti, il Venerdì 20 Giugno 2025
VT103
CAS:2290608-13-6
VT103, an oral TEAD1 palmitoylation inhibitor, shows promise against various cancers by disrupting YAP/TAZ-TEAD interactions.
Formula:
C18H17F3N4O2S
Purezza:
98.73%
Colore e forma:
Liquid
Peso molecolare:
410.41
Ref: TM-T62077
| 1mg | 124,00 € | ||
| 5mg | 298,00 € | ||
| 10mg | 472,00 € | ||
| 25mg | 817,00 € | ||
| 50mg | 1.198,00 € | ||
| 100mg | 1.730,00 € | ||
| 200mg | 2.337,00 € | ||
| 1mL*10mM (DMSO) | 328,00 € |
Consegna stimata in Stati Uniti, il Giovedì 26 Giugno 2025
